Repair of Large Incisional Hernias - To Drain or Not to Drain Randomised Clinical Trial
NCT ID: NCT02163460
Last Updated: 2014-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
42 participants
INTERVENTIONAL
2012-05-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non Absorbable Mesh Reinforcement of Midline Incision Closure in High Risk Patients, Onlay Versus Preperitoneal Position, a Comparative Clinical Trial
NCT04145908
Prophylactic Mesh to Reduce The Incidence of Ventral Hernia
NCT01788826
Full-thickness Skin vs. Synthetic Mesh in the Repair of Large Incisional Hernia
NCT01413412
The Use of Local Hemostatic in Patients With Large Incisional Hernias
NCT04222517
Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias
NCT05734222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study design and randomisation followed the Consolidated Standards of Reporting Trials (CONSORT) version 2010 15.
All the participants read and signed an informed consent form at the preoperative assessment visit.
Inclusion and exclusion criteria Individuals with primary or recurrent incisional hernia were assessed at HUOP, and those with longitudinal or transverse ventral hernia secondary to a previous surgical incision, measuring 5 to 15 cm after dissection of the hernial sac and classified as large or very large according to Chevrel's classification, were considered to be eligible16. In individuals with multiple defects, the length between the cranial margin of the most cranial defect and the caudal margin of the most caudal defect was considered17. Individuals subjected to emergency surgery, with infection, immunosuppressed, younger than 18 or older than 80 years old, ASA III or IV, with a serum albumin concentration lower than 3.0 g/dl or who refused participation were excluded from the study.
Surgical technique The participants were admitted to the hospital the night before surgery to perform or update the assessment of their surgical risk according to the American Society of Anesthesiologists (ASA) criteria, as well as for measurement of the serum albumin concentration.
Incisional herniorrhaphy surgery was performed following the group's technique systematisation by a resident physician supervised by one of four surgeons professors at the medical course of UNIOESTE and who the using the onlay technique as described by Chevrel18-20. Antibiotic prophylaxis was performed with a single 2 g dose of cefazolin at the time of anaesthetic induction followed by a booster 1 g dose when the surgery lasted more than three hours.
The aponeurosis was dissected 5 cm beyond the aponeurotic defect. Approximation of the aponeurotic margins for midline reconstruction was performed using polyglactin 910 #1 sutures. Tension was relieved by releasing incisions performed on the external oblique muscle aponeurosis, 3 cm away from the linea alba, as described by Gibson21. A macroporous polypropylene monofilament P1 mesh of 100 g/m2 (Cousin Biotec) was fixed on the aponeurosis by separate 2-0 polypropylene sutures performed every 2 cm.
The participants were randomised immediately after mesh fixation by a computer-based random number generator and allocated to the two intervention groups.
Interventions In group 1, a 4.8 mm diameter continuous closed-suction tubular drain (Medsharp Ind.Com.Prod.Hosp.Ltda - reg. MS (Ministério da Saúde \[Health Ministry registry\]): 80267170001) was placed between the aponeurosis and the subcutaneous tissue caudally to the incision. Next, the subcutaneous tissue approximation was performed with separate absorbable polyglactin 910 2/0 sutures.
Drains were not used in group 2, but separate absorbable polyglactin 920 2/0 sutures were placed from the subcutaneous mesh to the aponeurosis every 2 cm by means of the progressive tension suture (or Quilting Sutures) technique, as described by Pollock et al.10-13.
Skin closure was performed with simple separate sutures at 1 cm intervals using nylon monofilament suture #4-0 in both groups. The participants were requested to use the support girdles provided by the surgical staff at the hospital and at home during the first 30 days after surgery.
In group 1, the drains were removed when the drained volume was less than 40 ml/24 hours.
Outcomes All the participants were clinically assessed by the attending staff to detect postoperative complications, seroma formation and surgical site infection, especially on postoperative (PO) days one, three, five, seven, 14-16 and 29-31. The data were recorded on a pre-established form.
All the participants were subjected to abdominal wall ultrasound to assess seroma formation at three time points defined as: early (PO days four to six), intermediate (PO days 14 to 16) and late (PO days 29 to 31). The tests were performed by the radiology staff at HUOP. Seroma was defined as the collection of any volume of subcutaneous fluid without debris. All the participants remained in the hospital until the first ultrasound assessment was performed. The presence of seroma was considered as the main outcome. Clinical seroma was defined as a visible bulge or fluctuation without signs of infection, subclinical seroma was defined as the absence of detectable abnormalities on physical examination but the presence of any volume of fluid collection on abdominal wall ultrasound, and seroma was defined as all occurrences of fluid collection detected on ultrasound.
Surgical wound infection was prospectively defined according to the criteria formulated by the Centers for Disease Control and Prevention (CDC) in the Guideline for Prevention of Surgical Site Infection, 1999 22.
Sample size calculation The sample size was calculated based on significance level alpha = 5% and 80% power. A two-tailed test for the comparison of the two proportions was used to compare the occurrence of seroma between the groups with drains (50.0%) or progressive tension sutures (10.0%)
Statistics The initial statistical analysis of all the data collected in the present study was descriptive. In regard to the quantitative (numerical) variables, summary measures including mean, standard deviation, median, maximum and minimum values were calculated, and one-dimensional scatterplots were constructed. The data corresponding to the qualitative (categorical) variables were assessed as absolute and relative (percent) frequencies.
Inferential analysis was performed to confirm or refute the evidence found in the descriptive analysis. For that purpose, Student's t-test for independent samples was used to compare the groups of participants.
In the inferential analysis, the significance level (α) was established as 5%. The statistical analyses were performed using software R version 2.15.2.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drain
In group 1(Drain), a 4.8 mm diameter continuous closed-suction tubular drain : was placed between the aponeurosis and the subcutaneous tissue caudally to the incision.
Drain
In group 1, a 4.8 mm diameter continuous closed-suction tubular drain (Medsharp Ind.Com.Prod.Hosp.Ltda - reg. MS (Ministério da Saúde \[Health Ministry registry\]): 80267170001) was placed between the aponeurosis and the subcutaneous tissue caudally to the incision.
Progressive Tension Sutures
Drains were not used in group 2, but separate absorbable polyglactin 920 2/0 sutures were placed from the subcutaneous mesh to the aponeurosis every 2 cm by means of the progressive tension suture (or Quilting Sutures) technique, as described by Pollock et al
Progressive Tension Sutures
Drains were not used in group 2, but separate absorbable polyglactin 920 2/0 sutures were placed from the subcutaneous mesh to the aponeurosis every 2 cm by means of the progressive tension suture (or Quilting Sutures) technique, as described by Pollock et al
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drain
In group 1, a 4.8 mm diameter continuous closed-suction tubular drain (Medsharp Ind.Com.Prod.Hosp.Ltda - reg. MS (Ministério da Saúde \[Health Ministry registry\]): 80267170001) was placed between the aponeurosis and the subcutaneous tissue caudally to the incision.
Progressive Tension Sutures
Drains were not used in group 2, but separate absorbable polyglactin 920 2/0 sutures were placed from the subcutaneous mesh to the aponeurosis every 2 cm by means of the progressive tension suture (or Quilting Sutures) technique, as described by Pollock et al
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In individuals with multiple defects, the length between the cranial margin of the most cranial defect and the caudal margin of the most caudal defect was considered
Exclusion Criteria
* Immunosuppressed
* Younger than 18 or older than 80 years old
* ASA III or IV, with a serum albumin concentration lower than 3.0 g/dl or who refused participation were excluded from the study
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Universidade Estadual do Oeste do Paraná
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andre P Westphalen, MD
Role: PRINCIPAL_INVESTIGATOR
Universidade Estadual do Oeste do Paraná
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western Paraná State University / Universidade Estadual do Oeste do Paraná
Cascavel, Paraná, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
009/2011-CEP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.